Pro-Dex, Inc. (PDEX)
NASDAQ: PDEX · IEX Real-Time Price · USD
18.61
-0.01 (-0.05%)
At close: May 1, 2024, 12:00 AM
18.41
-0.20 (-1.07%)
After-hours: May 1, 2024, 4:00 PM EDT

Pro-Dex Revenue

Pro-Dex had revenue of $48.24M in the twelve months ending December 31, 2023, with 9.03% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $12.59M with 11.58% year-over-year growth. In the fiscal year ending June 30, 2023, Pro-Dex had annual revenue of $46.09M with 9.62% growth.

Revenue (ttm)
$48.24M
Revenue Growth
+9.03%
P/S Ratio
1.35
Revenue / Employee
$332,717
Employees
145
Market Cap
65.34M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202346.09M4.05M9.62%
Jun 30, 202242.04M4.01M10.55%
Jun 30, 202138.03M3.20M9.17%
Jun 30, 202034.83M7.66M28.20%
Jun 30, 201927.17M4.71M20.95%
Jun 30, 201822.47M522.00K2.38%
Jun 30, 201721.94M2.75M14.35%
Jun 30, 201619.19M5.81M43.38%
Jun 30, 201513.38M2.57M23.78%
Jun 30, 201410.81M-1.44M-11.73%
Jun 30, 201312.25M-5.01M-29.02%
Jun 30, 201217.26M-6.80M-28.28%
Jun 30, 201124.06M849.00K3.66%
Jun 30, 201023.21M2.09M9.89%
Jun 30, 200921.12M-4.00M-15.94%
Jun 30, 200825.13M3.56M16.52%
Jun 30, 200721.56M4.50M26.39%
Jun 30, 200617.06M3.23M23.33%
Jun 30, 200513.83M-366.00K-2.58%
Jun 30, 200414.20M2.21M18.43%
Jun 30, 200311.99M1.46M13.91%
Jun 30, 200210.53M-4.32M-29.09%
Jun 30, 200114.84M-1.55M-9.48%
Jun 30, 200016.40M-1.94M-10.60%
Jun 30, 199918.34M-4.31M-19.01%
Jun 30, 199822.65M3.45M17.98%
Jun 30, 199719.20M-1.37M-6.68%
Jun 30, 199620.57M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SCYNEXIS 140.14M
Champions Oncology 49.22M
Celularity 14.79M
Ikena Oncology 9.16M
Asensus Surgical 8.58M
Revenue Rankings